跳至主要内容
临床试验/ACTRN12613001037796
ACTRN12613001037796已完成3 期

Effect of exercise intensity on cardiac and vascular function, and intra-abdominal fat in obese children and adolescents.

Professor Jeff Coombes0 个研究点目标入组 30 人开始时间: 2013年9月18日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
7 Years 至 16 Years(—)
性别
All

入选标准

  • Gender: Males and females are eligible. The study will endeavour to recruit approximately equal numbers of males and females.
  • Body mass index: Obese individuals, with a body mass index greater than or equal to an equivalent of 30kg/m2 in adults are eligible. Eligibility of obese individuals with a BMI greater than 99th percentile (CDC Growth Charts) will be assessed on an individual basis.
  • Age: Individuals aged 7-16 years old (inclusive) are eligible.
  • Ethnicity: All ethnic groups are eligible for the study. There is likely to be incidental recruitment of participants of Aboriginal or Torres Strait Islander ethnicity.
  • Blood pressure: Individuals with blood pressure less than the 95th percentile for systolic or diastolic values measured upon three or more occasions will be eligible
  • Lipid control: Individuals with fasting total cholesterol less than 5.5mmol/L and low-density lipoprotein cholesterol less than 3.0mmol/L are eligible.
  • Willingness to participate: Participants must be willing to be randomised to either High Intensity Aerobic Interval Training, Moderate Intensity Exercise or Control groups and to follow the protocol that they have been assigned.
  • Successful completion of self-monitoring: Successful seven accelerometer compliance and diet diary completion will be an indication of willingness to participate and will be required for eligibility

排除标准

  • - Unwilling to participate or participation in another study
  • - Coronary heart disease
  • - Congenital cardiac abnormalities (i.e. anomalous coronary artery origins)
  • - Family history of hypertrophic obstructive cardiomyopathy
  • - Any abnormality during the resting or exercise stress echo that indicates it would be unsafe to participate in the intervention
  • - Self reported kidney failure
  • - Any major organ transplant
  • - Considerable pulmonary disease including severe or poorly controlled asthma or exercise induced asthma
  • - Diabetes
  • - Epilepsy or history of seizures
  • - Orthopaedic and/or neurological limitations to exercise
  • - Diagnosed Attention Deficit Hypersensitivity Disorder (ADHD)
  • - Medications such as steroids
  • - Conditions not specifically mentioned above may serve as criteria for exclusion at discretion of the clinical site

研究者

发起方
Professor Jeff Coombes

相似试验